IDE and COVID-19: In addition, IDE expression was downregulated in COVID-19 patients 3 months after hospital discharge, revealing a sex- and metabolic-dependent regulation of IDE in monocytes, suggesting that its regulation might be important for the recruitment of immune cells to the site of infection and glucometabolic control in COVID-19 patients.